Using EBV transformation of primary B cells as an in vitro model, we showed that knockdown of endogenous Gal-9 or addition of exogenous Gal-9 impacted the establishment of EBV latent infection and the B-cell transformation process. The gene discussed is LGALS9; the disease is disease arising from reactivation of latent virus.